Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies is a research paper published in Molecular Carcinogenesis (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: T32CA174648
NIH
Grant: T32AR007411
NIH
Grant: T32GM007635
NIH
Grant: R01s DE024371
NIH
Grant: DE027329
NIH
Grant: DE028420
NIH
Grant: P50CA261605
NIDCR NIH HHS
Grant: R01 DE024371
BLRD VA
Grant: I01 BX003232
NIDCR NIH HHS
Grant: R01 DE028420
NIDCR NIH HHS
Grant: R01 DE027329
FWCI
0.41
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals